4D Molecular Therapeutics grants 260,000 stock options, 157,600 RSUs to 13 new employees
4D Molecular Therapeutics granted 13 new non-executive employees options to purchase 260,000 common shares on October 13, 2026. The awards included 157,600 restricted stock units under the company's amended 2025 Employment Inducement Award Plan. Disclaimer: This news brief was created by Public Technologies (PUBT) usin